These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 27668701)

  • 1. Bacterial fatty acid metabolism in modern antibiotic discovery.
    Yao J; Rock CO
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Nov; 1862(11):1300-1309. PubMed ID: 27668701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, inhibition, and regulation of essential lipid A enzymes.
    Zhou P; Zhao J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Nov; 1862(11):1424-1438. PubMed ID: 27940308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Bacterial Transglycosylase: Antibiotic Development from a Structural Perspective.
    Chen X; Wong CH; Ma C
    ACS Infect Dis; 2019 Sep; 5(9):1493-1504. PubMed ID: 31283163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecules that Inhibit Bacterial Resistance Enzymes.
    Liu Y; Li R; Xiao X; Wang Z
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30583527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery.
    Campbell JW; Cronan JE
    Annu Rev Microbiol; 2001; 55():305-32. PubMed ID: 11544358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blast from the Past: Reassessing Forgotten Translation Inhibitors, Antibiotic Selectivity, and Resistance Mechanisms to Aid Drug Development.
    Arenz S; Wilson DN
    Mol Cell; 2016 Jan; 61(1):3-14. PubMed ID: 26585390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial targets in fatty acid biosynthesis.
    Wright HT; Reynolds KA
    Curr Opin Microbiol; 2007 Oct; 10(5):447-53. PubMed ID: 17707686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: Antibiotic discovery in the age of structural biology - a comprehensive overview with special reference to development of drugs for the treatment of Pseudomonas aeruginosa infection.
    Koehnke A; Friedrich RE
    In Vivo; 2015; 29(2):161-7. PubMed ID: 25792642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments.
    Gautam A; Rishi P; Tewari R
    Appl Microbiol Biotechnol; 2011 Oct; 92(2):211-25. PubMed ID: 21822642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents.
    Wang Y; Ma S
    ChemMedChem; 2013 Oct; 8(10):1589-608. PubMed ID: 23894064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Extracellular Bacterial HtrA Proteins as Potential Therapeutic Targets and Vaccine Candidates.
    Skórko-Glonek J; Figaj D; Zarzecka U; Przepiora T; Renke J; Lipinska B
    Curr Med Chem; 2017; 24(20):2174-2204. PubMed ID: 28019638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, function and selective inhibition of bacterial acetyl-coa carboxylase.
    Polyak SW; Abell AD; Wilce MC; Zhang L; Booker GW
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):983-92. PubMed ID: 22183085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N
    Zhong W; Koay A; Ngo A; Li Y; Nah Q; Wong YH; Chionh YH; Ng HQ; Koh-Stenta X; Poulsen A; Foo K; McBee M; Choong ML; El Sahili A; Kang C; Matter A; Lescar J; Hill J; Dedon P
    ACS Infect Dis; 2019 Mar; 5(3):326-335. PubMed ID: 30682246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel FabH inhibitors: a patent and article literature review (2000--2012).
    Luo Y; Yang YS; Fu J; Zhu HL
    Expert Opin Ther Pat; 2012 Nov; 22(11):1325-36. PubMed ID: 22998551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013).
    Song H; Ao GZ; Li HQ
    Expert Opin Ther Pat; 2014 Jan; 24(1):19-27. PubMed ID: 24083428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis.
    Hering J; Dunevall E; Ek M; Brändén G
    Drug Discov Today; 2018 Jul; 23(7):1426-1435. PubMed ID: 29778697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging structural information for the discovery of new drugs: computational methods.
    Nguyen TB; Wong SE; Lightstone FC
    Methods Mol Biol; 2012; 841():209-34. PubMed ID: 22222454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
    Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
    Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the structural mechanisms of antibiotic resistance sets the platform for new discovery.
    Reeve SM; Lombardo MN; Anderson AC
    Future Microbiol; 2015; 10(11):1727-33. PubMed ID: 26516790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.